Home›Companies›Biotech & Pharma›Syndex Bio

Syndex Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 14, 2025·Suggest an edit

About Syndex Bio

Syndex Bio is a private company based in Santa Monica, California, incorporated in 2022 in Delaware. It has reported $15,506,942 raised in one offering on Form D since March 2025. Its chief executive is Geoff Smith.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 27, 2025Mar 14, 2025$15,506,942fully sold12$1.2MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Syndex Bio's Form D filed Mar 14, 2025.

GS
Geoff Smith
Chief Executive Officer and director

Sources

  1. SECSyndex Bio Inc. filing history